News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
194,774 Results
Type
Article (19265)
Company Profile (110)
Press Release (175399)
Section
Business (63548)
Career Advice (808)
Deals (8967)
Drug Delivery (68)
Drug Development (18570)
Employer Resources (137)
FDA (3294)
Job Trends (5953)
News (94625)
Policy (6995)
Tag
Academia (1483)
Alliances (17162)
Alzheimer's disease (484)
Antibody-drug conjugate (ADC) (46)
Approvals (3265)
Artificial intelligence (72)
Bankruptcy (46)
Best Places to Work (4831)
Biosimilars (40)
Biotechnology (67)
Breast cancer (37)
Cancer (329)
Cardiovascular disease (41)
Career advice (712)
Cell therapy (91)
Clinical research (13773)
Collaboration (191)
COVID-19 (940)
C-suite (55)
Data (347)
Diabetes (45)
Diagnostics (2375)
Drug pricing (39)
Earnings (14218)
Employer resources (117)
Events (28845)
Executive appointments (160)
FDA (3432)
Funding (165)
Gene therapy (70)
GLP-1 (279)
Government (1292)
Healthcare (4883)
Infectious disease (978)
Inflammatory bowel disease (45)
Interviews (112)
IPO (3584)
Job creations (1296)
Job search strategy (629)
Layoffs (143)
Legal (1164)
Lung cancer (59)
Management (41)
Manufacturing (83)
Medical device (2568)
Medtech (2572)
Mergers & acquisitions (5467)
Metabolic disorders (153)
Neuroscience (591)
NextGen Class of 2024 (2074)
Non-profit (1665)
Northern California (469)
Obesity (102)
Opinion (87)
People (26482)
Phase I (4075)
Phase II (5700)
Phase III (5466)
Pipeline (117)
Postmarket research (558)
Preclinical (2335)
Press Release (61)
Radiopharmaceuticals (59)
Rare diseases (73)
Real estate (2504)
Recruiting (53)
Regulatory (4890)
Research institute (1255)
Resumes & cover letters (106)
Southern California (310)
Startups (1988)
United States (3975)
Vaccines (163)
Weight loss (83)
Date
Today (7)
Last 7 days (212)
Last 30 days (988)
Last 365 days (11631)
2024 (10648)
2023 (12958)
2022 (15564)
2021 (17683)
2020 (16296)
2019 (14968)
2018 (10809)
2017 (10306)
2016 (10169)
2015 (10875)
2014 (8005)
2013 (6919)
2012 (7358)
2011 (7537)
2010 (7024)
Location
Africa (323)
Arizona (53)
Asia (11025)
Australia (1930)
California (935)
Canada (394)
China (78)
Colorado (54)
Europe (28439)
Florida (127)
Illinois (91)
Indiana (87)
Maryland (129)
Massachusetts (796)
Michigan (65)
Minnesota (86)
New Jersey (311)
New York (369)
North Carolina (233)
Northern California (469)
Ohio (46)
Pennsylvania (160)
South America (390)
Southern California (310)
Texas (133)
Washington State (85)
194,774 Results for "quotient sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Pfizer Partners With Flagship’s Quotient to Leverage Genetics Against Heart, Renal Diseases
Quotient Therapeutics’ platform targets somatic mutations, which the startup contends can help identify a broader scope of genes potentially associated with disease phenotypes. Wednesday’s agreement is part of an existing partnership between Pfizer and Flagship Pioneering.
August 28, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Quotient Therapeutics Appoints Sir Mene Pangalos, Ph.D. to Board of Directors
November 8, 2024
·
3 min read
Press Releases
Quotient Therapeutics Appoints Peter Campbell, Ph.D. as Chief Scientific Officer
August 7, 2024
·
2 min read
Press Releases
Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer
August 28, 2024
·
4 min read
Biotech Beach
Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform
Ensysce Biosciences, Inc. today announced the renewal of its collaboration with Quotient Sciences to undertake the study PF614-MPAR-102 to examine and evaluate the full commercial dose range of the PF614-MPAR drug product.
May 20, 2024
·
5 min read
Job Creations
Massachusetts Increases Life Sciences Investment by $500M Over 10 Years
Massachusetts’ increased investment in the life sciences industry includes boosting its life sciences tax incentive program by $10 million annually, aiding job creation in the state.
November 21, 2024
·
2 min read
·
Angela Gabriel
Biotech Beach
Ensysce Biosciences Announces Poster Presentation at the AAPS 2023 PharmSci 360
Ensysce Biosciences, Inc. today announced Dr. Dolly Jacob, Director Integrated Development Services of Quotient Sciences, will present the collaborative work of Ensysce and Quotient Sciences in a poster.
October 18, 2023
·
4 min read
Business
Nanomerics Announces Quotient Sciences as its Clinical Trials Partner
Nanomerics Ltd., a private speciality pharmaceutical company, announced that the Company had signed an agreement with Quotient Sciences, a drug development and manufacturing accelerator, for the delivery of its Sunlight Trial.
March 28, 2022
·
4 min read
Policy
Quotient Limited Announces Intent to Voluntary Delist from the Nasdaq Global Market
Quotient Limited announced that it has given formal notice to the Nasdaq Stock Market LLC of its intention to voluntarily delist its ordinary shares from the Nasdaq Global Market.
December 12, 2022
·
3 min read
Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics
Quotient Limited announced an agreement with Theradiag, a market leader in autoimmune disease testing and pioneer in theranostics, under which the two companies will partner to advance autoimmune diagnostics by leveraging Quotient’s MosaiQ platform.
June 8, 2022
·
7 min read
1 of 19,478
Next
